Brevan Howard Capital Management LP Merck & Co., Inc. Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 82,648 shares of MRK stock, worth $7.39 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
82,648
Previous 11,267
633.54%
Holding current value
$7.39 Million
Previous $1.28 Million
542.77%
% of portfolio
0.06%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,959Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$22.4 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$18.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10.8 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.22 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.47 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $226B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...